UPC SCENARIO MEDICAL DEVICES. Insomnia, Brexit and the UPC: a fictional scenario
|
|
- Barry Warren
- 6 years ago
- Views:
Transcription
1 UPC SCENARIO MEDICAL DEVICES Insomnia, Brexit and the UPC: a fictional scenario In our latest article looking at a UPC scenario, Nicola Dagg, Marc Döring, Alex Woolgar, David Por, Philipp Cepl and Laura Thompson consider a case that raises questions about jurisdiction, discovery and Brexit 1READ MINUTE This fictional UPC scenario explores some issues of jurisdiction as between UPC states. The scenario centres on a medical device, which comprises both pharmaceutical and electronic communications elements. The patents in suit are Unitary Patents. The UPC has recently opened for business, as the required 13 countries have ratified the UPC Agreement, but at this stage no further ratifications are complete. A large amount of artistic licence has been used in creating this scenario. Its purpose is not to present all details and correct answers; it is for illustrating law, rules, and strategy, and for provoking thoughts on how the UPC may deal with some difficult issues as the system begins to operate, which are further complicated by the prospect of Brexit. Read more UPC scenarios at managingip.com/upc In this fictional scenario our client is US-based innovative pharmaceutical company, Jones Pharma Inc. Jones manufactures and markets worldwide a medical device for the treatment of insomnia and related sleep disorders, branded SeroNight. SeroNight is a transdermal patch containing a slow-release gel formulation of prospirone, a selective serotonin reuptake inhibitor. Jones originally developed (and still markets, also in slow-release gel patch form) this SSRI for treatment of anxiety. Sales for the treatment of anxiety now make up around 10% of the prospirone market. The compound patent for prospirone expired earlier this year. Unlike Jones anxiety treatment, SeroNight patches also contain a microprocessor, which (via microcurrent stimulation) controls the rate of release of prospirone. The processor is able to communicate wirelessly (via a (fictional) industry standard communications protocol, Starlight Electronic Pulsatory Prevention of Insomnia SLEEPPI) with a number of off-the-shelf wearable tracker devices, which collect data on indicators such as heart rate and movement. Using data collected from the tracker, Jones s proprietary software installed on the SeroNight processor is able to monitor sleep quality and sleep state, and adjust the rate of prospirone release accordingly to maximise efficacy and minimise morning drowsiness. Jones has two relevant subsisting European patents: a patent protecting the use of prospirone for the treatment of insomnia and related sleep disorders (in EPC 2000 form); and 24
2 a patent protecting the process by which the SeroNight microprocessor receives and analyses data from the tracker device, modulates microcurrent output and adjusts the pharmaceutical release rate accordingly. Both were granted after the start of the UPC transitional period, and Jones opted for these to have unitary effect, meaning they cover the 13 UPC states which had ratified the UPC Agreement (UPCA) at the time of grant; Jones is aware that country coverage will not increase even as more countries ratify the UPCA later. A significant question for Jones is: which factors will be influential in the court s decision on whether to grant provisional measures? While you were napping SmithTech plc is a healthcare company based in South Africa, which has interests in generic pharmaceuticals, but predominantly in medical device markets. Through its regular monitoring activities, Jones has become aware that Smith has been granted a European marketing authorisation for prospirone in slow-release gel form. The summary of product characteristics (SmPC) and patient information leaflet (PIL) are not yet available online. There is reason to believe that Smith is about to import a new transdermal patch product into the EU via Rotterdam, the Netherlands. Jones has contacted Smith for urgent clarification of its commercial intentions, but has received no response. (It later transpires (i) Smith has not tried to clear the way to market for its product, taking the view that it does not infringe, and so decided to launch at-risk; and (ii) as an alternative strategy, Smith considered filing a protective letter at the UPC Registry (under UPC Rule of Procedure (RoP) 207) but owing to administrative error (Smith did not pay the requisite fee under RoP 207(4)) it did not put this into effect properly in time to block enforcement efforts by Jones. Perhaps I m only dreaming preparing to resolve the dispute The board of Jones is anxious to take action quickly to obtain the best possible outcome for the company, whether this will be in court or settled out of court. With this in mind, Jones s lawyers advise on the options available (which are found in Articles of the UPCA). These are shown in figure 1. A significant question for Jones is: which factors will be influential in the court s decision on whether to grant provisional measures? Any UPC panel will have a multinational composition (Article 8(1) UPCA), although the precise composition will depend on location. The jurisdictional background of each UPC judge is likely to be a factor in their consideration of procedural and substantive matters, especially to fill in the blanks where the specified sources of substantive law (Article 24 UPCA) such as EU law, the UPCA, the European Patent Convention, and the national law of the seat of the particular UPC division, do not provide much detail (see figure 2). UPC decisions blending many national approaches are likely to increase over time, as more cases are heard by the UPC and a body of case law develops. Although earlier decisions will not provide binding precedent, no doubt they will be persuasive. The stuff of nightmares preparing to launch litigation Jones opted to bolster its evidence position by successfully applying for a saisie. The saisie confirms that Smith has gained CE marking and medical device conformity approval for a microchipped transdermal patch containing prospirone, called the ProsPro. Smith intends to launch this product imminently. Smith s attitude has destroyed any prospect of mediation. Jones immediately launches a full infringement action, based on both patents, in the Netherlands local division. The court, exercising principles of active case management (RoP 332), is content for the actions relating to both patents to be heard together (RoP 334(i)). Jones applies for an interim injunction, pending full pleadings (as permitted under RoP 206(1)). Smith argues that there is no infringement because its product is targeted toward the market for anxiety, and is not intended for use in treating sleep disorders. The court is unconvinced, and an interim injunction is granted. Full pleadings are exchanged. Smith responds with a defence of non-infringement and a counterclaim for revocation of both patents. Smith also alleges that the communications protocol used by the SeroNight necessarily infringes one of Smith s patents, which Smith has declared essential to the SLEEPPI standard. Smith asserts that the infringement action should be stayed pending the outcome of the revocation action, which should be transferred to the Paris Central Division. The only way is Paris Smith wants the action transferred to Paris because of that court s remit for hearing disputes in the high-tech or electronic arts (UPCA Article 7(2) and Annex II). Smith contends the nub of the dispute is about the technology of the microchip and its communication method; pharmaceuticals will not be the focus. Most expert evidence (assuming the court permits expert evidence see RoPs 112(2)(b) and 181) will need to be on the electronics side of the dispute. This is particularly relevant given that Smith is also considering launching a declaration of 25
3 It becomes clear that the saisie has not provided sufficient information to prove infringement of the process patent non-infringement (DNI) action based on a design-around device it has created: the pharmaceutical formulation has been changed slightly, but the communication method on the patch chip has been changed substantially. Therefore, Smith contends the dispute overall should be characterised as high-tech and heard in Paris. London calling Jones disagrees with Smith s position, protesting that a stay of the Dutch action will cause delay and price erosion resulting from Smith s cheaper product. This is made possible because Smith s components are inferior in quality. Jones prides itself on its reputation for impeccable quality, for which customers are willing to pay extra. For example, Jones s product contains thicker patch casing, to better insulate the chip from radio frequency interference this can affect the delicate asneeded dosing feature (if the electronic protocol is sent offplan, this causes a transdermal release of an under- or over-dose of the SSRI). Alternatively, Jones contends that under UPCA Articles 33(3)- (4), transfer is not mandatory, even if the DNI action is commenced. However, if the action is to be transferred to the Central Division (and there is some indication Jones will agree to this transfer provided the action is not stayed), Jones argues London is the correct Central Division court for hearing the dispute. Jones reasons are: UPCA Article 7(2), and particularly Annex II regardless of the nature of the alleged infringing product, and the existence of the electronic aspect, the Jones microprocessorcontrolled pharmaceutical release-related patent is WIPO IPC classified on the front page in such a way that definitively dictates that the action should be in London (and, of course, the classification of the prospirone patent even more clearly indicates the subject matter is for the London court); and even if the court were persuaded to look beyond the IPC class alone to the nature of the product in suit, then it still falls within the human necessities classifications which are the London court s remit. It is true that there is an electronic element, but this is a medical device, and the term human necessities is defined much more broadly than just covering pharmaceuticals or chemicals. Jones is also considering an argument which rebuts Smith s threatened counter-infringement claim on the standard-essential patent; but this argument involves a complex interplay between SEPs, FRAND and the European medical device regulation regime insofar as it applies to certain health-related software programs. It is possible that a question on this issue will need to be preliminarily referred to the CJEU. As with all local divisions in which less that 50 cases per year have been started, the Netherlands local division comprises a panel of three legally qualified judges (one Dutch, and English and French judges allocated from the central pool (see Article 8 UPCA). Eventually, the case (on both patents) is transferred to the London section of the Central Division. Rapid Eye Movement keeping the litigation ticking over It becomes clear that the saisie has not provided sufficient information to prove infringement of the process patent. It is unclear whether the method of microcurrent adjustment used in the Smith product falls within the scope of the claims. Jones, being a large US client accustomed to obtaining substantial discovery and depositions, is extremely keen to obtain a similar level of information in these European proceedings. Jones s lawyers explain that wide-ranging discovery is not the default order for the UPC. Instead, Jones applies under RoP 190(1) (with the support of evidence) at the interim conference (RoP 104(e)) for an order for specific disclosure of internal documents recording deliberations among Smith executives relating to the possible design-around. Smith and Jones are able to agree (prior to the conference) an order for expert evidence from pharmacokinetics and software development experts. Following Smith s disclosure, Jones may need a further expert (such as a materials scientist) to prepare an expert report. In this case, Jones will need to apply to the assigned judge rapporteur for an order under RoP 112(2)(b) for the expert s evidence to be heard at trial. Waking up to a cooked Brexit At the time of writing, a complicating factor is the potential for Brexit to reshape the UPC system. On March , the UK government invoked Article 50(1) of the Lisbon Treaty, so the UK leaving the EU within two years is a real possibility. (This was followed, in April, by the calling of a general election to be held on June 8.) In our view, there are broadly three possible outcomes: UK leaves EU and immediately leaves the UPC system. It seems unlikely this will happen if the UK is in the UPC system from the beginning of its operations. While the UPCA does not provide for countries that are not EU member states to belong to the system, equally there is also no mechanism for a country to leave the Unitary Patent/UPC system. London is named in the UPCA as one of the locations for a section of the Central Division of the Court. Without amendment 26
4 Figure 1 Application for preliminary measures/preliminary injunction (RoP 206) Court can grant this before full proceedings have begun Could prevent Smith launching/continuing to import and sell its product Signals to the wider marketplace that Jones is serious about enforcing its rights against infringers To succeed, Jones needs enough evidence, eg as to harm it will suffer, and presently it does not have much Requires an oral hearing Discretionary remedy, so Jones might not obtain it Uncertain approach in the UPC early days, about how the judges from various jurisdictions in multi-national panels will decide these applications Attempt to mediate, to obtain settlement using a new Mediation Centre set up pursuant to UPCA Art. 35, it is located in Lisbon, Portugal; this is (fictionally, for this scenario) called the UPC Office for Real Dispute Alleviation (UPCORDIALE) Avoids expense and risk/uncertainty of patent litigation outcomes Outcome of any deal reached could be kept confidential (subject to local financial regulatory filing requirements eg in USA) May take some time to achieve a result, or, none may be achieved, so might just delay inevitable litigation Does not deliver a public judgment that could be useful in other proceedings/territories Smith is not prevented from launching/continuing to sell product in meantime Specific (pre-action) disclosure/discovery (RoP 190(2)) Court can grant this any time Could provide more detailed evidence on which Jones can base its claim Jones cannot have all the possible disclosure/discovery it wants/thinks exists; it will have to make its request specific to certain types of issues Smith may object, saying wait until you have seen the written statements of case once proceedings commence Apply for saisie - an order to preserve evidence and/or for inspection (RoP 192) Court can grant before proceedings start Could produce earlier access to the potentially infringing goods or materials used to make them Can ask for this without giving prior notice to Smith (RoP 192.3) but see box opposite Trying to do so without alerting Smith, requires giving the court full reasons why Smith should not be heard; Court may be unwilling to grant saisie without alerting Smith. Court may refuse, so Smith will need to be heard, adding delay and cost Smith would be notified at time of execution, and can ask for the order to be reviewed (RoP 197) 27
5 How can patentees best prepare for any effect of Brexit on the UPC? The ideal contingency would perhaps be to file simultaneously UK national and Unitary Patent (with a UK designation) applications for the same invention to the UPCA, however, London/the UK would only be able to remain on an informal basis (without the support of legislation). This calls into question whether judgments of the London section of the Central Division would be recognised and enforced by the courts of other UPC states. If the UK leaves immediately, the most likely scenario is that the proceedings are remitted to a replacement section of the Central Division (perhaps in Italy at present the most likely, or the Netherlands). UK leaves EU and stays in the UPC system permanently. Many IP practitioners and industry representatives in Europe would like to see the UK remain in the UPC. In our view, CJEU Opinion 1/09 sets out one viable mechanism for an ex-eu UK to remain a member. This Opinion does not explicitly restrict UPC membership to EU member states, but rather it requires that UPC states must (i) respect the supremacy of EU law; (ii) enable private individuals to bring claims against the member state: and (iii) ensure legal uniformity through references to the CJEU. This could be achieved through bilateral agreement between the EU and the UK, although in practice any such agreement will require substantial work. The main sticking point will be the requirement that, so far as it affects the UPC (for example, in matters of patent and competition law), EU law must be supreme and the CJEU must be deferred to. It is strongly questionable whether this will be politically palatable for the UK government. If the UK stays in the UPC system permanently, the proceedings between Smith and Jones will carry on more or less undisturbed (it is more likely than not that the CJEU reference will also continue as planned). UK leaves EU and stays in the UPC system for a transitional period, then leaves the system. As mentioned above, because there is no express legal mechanism of departure from the Unitary Patent or UPC systems, this kind of gentle exit would need to be agreed between all the UPC member states. In practice, the London section of the Central Division would need to stop accepting newly filed cases, but (for the sake of smooth transition) it would probably continue to hear the trials of pending first instance claims. Articles 20 and 21 of the UPCA indicate that the UPC must apply European Union law and respect its primacy, and be bound by decisions of the CJEU on preliminary references under Article 267 TFEU. In fact, for any transitional period, the London section will probably need to respect the criteria of Opinion 1/09. So how will these possibilities affect the course of the present litigation? The possibilities seem to be: First instance proceedings conclude before Brexit occurs. Provided there is no remission from the Court of Appeal in Luxembourg, Brexit has no effect on this case. First instance proceedings conclude; the appeal is heard in the Court of Appeal, and the infringement finding and consequent injunction are upheld. Brexit occurs shortly after. What happens to the enforceability of this injunction? The UK will need to create a mechanism for recognition and enforcement of the UPC judgment. At present, it appears that the UK could either sign up to the Lugano Convention instead of the (recast) Brussels Regulation (which governs jurisdictional issues as between EU member states), or take the Danish approach. The latter approach would not involve signing up to either the Lugano Convention or the Brussels Regulation, but instead in essence means codifying in domestic legislation the parts of the Brussels Regulation the UK wants to use. In our view, the UK is likely to put in place a pragmatic solution for the recognition and enforcement of foreign judgments. This is an essential part of UK efforts to maintain the worldwide importance of the UK as a dispute resolution forum (and location of choice for governing law) not only for patent disputes, but in many types of disputes. Proceedings are pending before the London section of the Central Division and the trial has been scheduled, but before trial takes place, the UK exits the EU. What happens to these pending proceedings? The only pragmatic course is that the trial (which was scheduled before Brexit) goes ahead in the London section (any appeal will go to Luxembourg in any event). The alternative is that the proceedings have to be moved to whichever country is able to seize control of a replacement section of the Central Division (whether this is Italy, the Netherlands or another location). A number of administrative and transitional measures would need to be put in place for this to occur. How can patentees best prepare for any effect of Brexit on the UPC? The ideal contingency would perhaps be to file simultaneously UK national and Unitary Patent (with a UK designation) applications for the same invention. The UK government has previously indicated that such doublepatenting will not be an option. Will the question of doublepatenting be reconsidered, as a fallback position? Changes have already been made to the Patents Act 1977 in the UK to reflect implementation of the Unitary Patent and UPC systems. These changes were made after UK consultations, but those consultations took place before the June 2016 referendum. Failing provision of a fallback option, innovators should look carefully at their pipeline and the probable timelines for the grant of current applications. It will be possible to opt-out from unitary effect patents filed before or during, and granted during, the UPC transitional period; therefore, for some patents, the contingency may simply be to take a view as the time of grant approaches. For others, it may be better to consider a bundle of national designations in a selection of key markets. 28
6 Figure 2: some national local colour similarities/differences UK Rigorous scurtiny of patent validity including cross-examination of experts Disclosure/Product and Process description Preliminary injunctions (PIs) may be available Loser pays major portion of winner s actual costs Other declarations Netherlands Rigorous scurtiny of validity PIs may be available No discovery/disclosure France Saisie contrefacon; on minimal evidence PI available for strong cases (no urgency requirement) Provisional damages and destruction of infringing goods possible Germany PIs may be available Bifurcation Infringement courts often patentee friendly; infringement heard before validity; No discovery/disclosure Protective letters system At the end of the day (or night) Leaving aside Brexit, there are many permutations of how this fictional litigation might unfold, but those we think most likely are: Jones is successful in all of its applications to obtain disclosure (European/UK-style rather than US style) and to bring expert evidence into the case. Jones gets a permanent injunction, and the connected corrective measures it has requested under Article 64 of the UPCA to recall the products from the supply chain. Jones recovers damages and almost all of the allowable costs. Jones s strategy was insightful. It achieved its commercial aim despite the uncertainties of the impact of Brexit on the UPC. Let us hope its injunction as ordered in the UPC remains enforceable in the UK! Jones secures a partial win, but the court decides in its discretion (under UPCA Article 63) not to order an injunction against Smith; Jones appeals this. The court also found the patents partially invalid, and so there was partial revocation and amendment (as per UPCA Article 65). Jones decides to appeal this partial invalidity finding to the Luxembourg Court of Appeal because, strategically, it needs the broader claims, to protect its interests in other non-european markets. Jones must continue to litigate and hope for a win on appeal. If the UK ended up outside the UPC, Jones must also hope that the UK will agree a practical regime for enforcement of any remedies it is awarded in the UPC Court of Appeal. Jones s Unitary Patents are revoked for being obvious. The court may decline to rule on infringement if so. Jones appeals the revocation order; the revocation is held in suspense pending the appeal outcome (UPCA Article 74(2)). Jones fight goes on: the CEO lies awake at night worrying about whether he should have instead opted for a small basket of national European patent designations and stuck to national patent litigation rather than risking all in the UPC. He reaches for his SeroNight Nicola Dagg Marc Döring Alex Woolgar David Por Philipp Cepl Laura Thompson Allen & Overy Nicola Dagg and Marc Döring are partners, Alex Woolgar is an associate and Laura Thompson is a senior PSL/senoir asociate in the firm s London office. David Por is a partner in Paris and Philipp Cepl is counsel in Düsseldorf 29
UPC FUTURE OF PATENT LITIGATION IN EUROPE. Alexander Haertel
UPC FUTURE OF PATENT LITIGATION IN EUROPE Alexander Haertel MAIN TOPICS What will happen? - The Unified Patent Court (UPC) will change the landscape of patent litigation in Europe - It is a front-loaded
More informationPROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION
PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION The idea of a Community Patent, a single patent that can be enforced throughout the European Union (EU), is hardly new. The original
More informationthe UPC will have jurisdiction over certain European patents (see box The unitary patent and the UPC: a recap ).
THE UNITARY PATENT CENTRAL ENFORCEMENT OF PATENTS IN EUROPE In the second of a two-part series, Susie Middlemiss, Adam Baldwin and Laura Balfour of Slaughter and May examine the structure and procedures
More informationThe Unitary Patent Unified Patent Court. Taylor Wessing LLP
The Unitary Patent Unified Patent Court Taylor Wessing LLP The European patent reform package The European patent reform package new legal bases > Proposed EU regulations (x2) on: Council/Parliament Regulation
More informationThe Unified Patent Court explained in detail. Managing Intellectual Property European Patent Reform Forum 19 September 2013 Munich
The Unified Patent Court explained in detail Managing Intellectual Property European Patent Reform Forum 19 September 2013 Munich The Panel Alex Wilson Lawyer Powell & Gilbert London Christine Kanz Lawyer
More informationThe EU Unitary Patent System in its current state. EU-Japan Policy Seminar 22 November 2016
The EU Unitary Patent System in its current state EU-Japan Policy Seminar 22 November 2016 in force since January 20, 2013 Overview on the Unitary Patent System The European Patent with unitary effect
More informationTHE NEW EUROPEAN UNIFIED PATENT COURT & THE UNITARY PATENT
THE NEW EUROPEAN UNIFIED PATENT COURT & THE UNITARY PATENT November 2015 Washington Kevin Mooney Simmons & Simmons LLP The Current Problems with enforcement of European patents European Patent Convention
More informationPatent litigation. Block 2. Module Jurisdiction and procedure Complementary reading: Unified Patent Court Agreement ( UPCA )
Essentials: Patent litigation. Block 2. Unified Patent Court Agreement ( UPCA ) PART I - GENERAL AND INSTITUTIONAL PROVISIONS The Unified Patent Court (UPC) will be a specialised patent court common to
More informationUnitary patent and Unified Patent Court: the proposed framework
Unitary patent and Unified Patent Court: the proposed framework The adoption of two key regulations late last year have paved the way for the long-awaited unitary patent and Unified Patent Court By Rainer
More informationEuropean Unitary Patents and the Unified Patent Court
European Unitary Patents and the Unified Patent Court Kevin Mooney July 2013 The Problem European Patent Convention Bundle Patents Single granting procedure but national enforcement No common appeal court
More informationPATENT SYSTEM STATUS OFREFORMS
THE UNITARY PATENT SYSTEM STATUS OFREFORMS 1. STATUS OF REFORMS* On December 11, 2012 the EU Parliament approved the implementation of the Unitary Patent System based on a Unitary Patent Regulation (Council
More informationUNIFIED PATENT SYSTEM: A NEW OPPORTUNITY FOR INTELLECTUAL PROPERTY IN EUROPE
March 2013 UNIFIED PATENT SYSTEM: A NEW OPPORTUNITY FOR INTELLECTUAL PROPERTY IN EUROPE After four decades of negotiations, on 19 February 2013 24 EU states signed the agreement on a Unified Patent Court
More informationIP IN A POST-BREXIT EUROPE ENSURING YOUR EUROPEAN IP RIGHTS ARE PROTECTED DATE: 10 NOVEMBER 2016 PRESENTERS: CHRIS FINN, BEN GRAU AND GRAHAM MURNANE
IP IN A POST-BREXIT EUROPE ENSURING YOUR EUROPEAN IP RIGHTS ARE PROTECTED DATE: 10 NOVEMBER 2016 PRESENTERS: CHRIS FINN, BEN GRAU AND GRAHAM MURNANE BACKGROUND A fundamental aspect of the European Union
More informationEuropean Patent with Unitary Effect
European Patent with Unitary Effect and the Unified Patent Court May 2013 Dr Lee Chapman lchapman@jakemp.com www.jakemp.com Where are we? Regulations relating to the EPUE and translation arrangements were
More informationUPC Alert. March 2014 SPEED READ
March 2014 UPC Alert SPEED READ Recent events signal that the radical change to how patents are obtained and enforced in and in particular involving Europe the new European Unified Patent Court (UPC) is
More informationPreliminary set of provisions for the Rules of procedure of the Unified Patent Court
27 January 2012 Preliminary set of provisions for the Rules of procedure of the Unified Patent Court Status 1. First draft dated 29 May 2009 discussed in expert meetings on 5 June and 19 June 2009 2. Second
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 27 September /12 PI 113 COUR 66 WORKING DOCUMENT
COUNCIL OF THE EUROPEAN UNION Brussels, 27 September 2012 14268/12 PI 113 COUR 66 WORKING DOCUMENT from: Presidency to: Delegations No. prev. doc.: 17539/11 PI 168 COUR 71 Subject: Draft agreement on a
More informationDr Julian M. Potter February 2014
The European Patent Court and Unitary Patent Don t Panic Be Prepared Dr Julian M. Potter February 2014 (c) Dr Julian M Potter 2014 1 Patent in Europe - now National patents through respective national
More informationLitigation Strategies in Europe MIP Global IP & Innovation Summit
Litigation Strategies in Europe MIP Global IP & Innovation Summit Paul Brown, Partner, London 4 September 2013 What will this talk cover? What factors does a litigant need to consider when litigating patents
More informationDehns Guide to the Unitary Patent and Unified Patent Court
Dehns Guide to the Unitary Patent and Unified Patent Court Contents Introduction 1 Part I: The Unitary Patent 2 Part II: The Unified Patent Court 16 Part III: Implications for Brexit 32 Summary: How Dehns
More informationPatent litigation in Europe Major changes to come. Anne-Charlotte Le Bihan, Partner, Bird & Bird ABPI, Rio de Janeiro August 20, 2013
Patent litigation in Europe Major changes to come Anne-Charlotte Le Bihan, Partner, Bird & Bird ABPI, Rio de Janeiro August 20, 2013 Introduction: Patent litigation in Europe today and tomorrow Patent
More informationRules of Procedure ( Rules ) of the Unified Patent Court
18 th draft of 19 October 2015 Rules of Procedure ( Rules ) of the Unified Patent Court Preliminary set of provisions for the Status 1. First draft dated 29 May 2009 Discussed in expert meetings on 5 June
More informationDraft agreement on a Unified Patent Court and draft Statute - Revised Presidency text
COUNCIL OF THE EUROPEAN UNION Brussels, 26 October 2011 16023/11 PI 141 COUR 62 WORKING DOCUMENT from: Presidency to: Delegations No. prev. doc.: 15539/11 PI 133 COUR 59 Subject: Draft agreement on a Unified
More informationEuropean Patent with Unitary Effect and
European Patent with Unitary Effect and Unified dpatent t 20 th Annual Conference on Intellectual Property Law & Policy at Fordham IP Law Institute April, 12 th 2012, New York by Dr. Klaus Grabinski Federal
More informationPatent reform package - Frequently Asked Questions
EUROPEAN COMMISSION MEMO Brussels, 11 December 2012 Patent reform package - Frequently Asked Questions I. Presentation of the unitary patent package 1. What is the 'unitary patent package'? The 'unitary
More informationEuropean Patent Law. Gwilym Roberts Daniel Brook
European Patent Law Gwilym Roberts Daniel Brook Overview 4-minute reminder of the system Cost/benefit of litigating with UPC Projected cost of patenting with UP Forum shopping? Troll heaven? Case studies
More informationEffect of Brexit on IP protection
Effect of Brexit on IP protection Contents Introduction 1 Patents 2 UK Patents 6 International Patent Applications 7 Unitary Patent and Unified Patent Court 8 Supplementary Protection Certificates 10 Plant
More informationRules of Procedure for UPC
Rules of Procedure for UPC Interim/Oral procedure Evidence Provisional measures Final remedies Enforcement Appeal 22 April 2013 Ben Hall Interim Procedure: Rules 101-110 The JR must make all necessary
More information13345/14 BB/ab 1 DG G3
Council of the European Union Brussels, 19 September 2014 (OR. en) 13345/14 PI 108 MI 672 IND 254 INFORMATION NOTE From: To: Subject: Presidency Council Competitiveness Implementation of the Patent package
More informationEuropean Patent Litigation: An overview
European Patent Litigation: An overview Tuesday 28 September 2010 Hogan Lovells in partnership with the Association of Corporate Counsel Europe Your speaker panel Co-Chairs: Marten Bezemer Associate General
More informationThe Unitary Patent & The Unified Patent Court IP Key & Centre for Commercial Law Studies, Queen Mary University of London 8 November 2016
The Unitary Patent & The IP Key & Centre for Commercial Law Studies, Queen Mary University of London 8 November 2016 Pierre Véron Honorary President EPLAW (European Patent Lawyers Association) Member of
More informationUNIFIED PATENT COURT (UPC) Einheitliches Patentgericht (EPG) Juridiction Unifiée du Brevet (JUB)
UNIFIED PATENT COURT (UPC) Einheitliches Patentgericht (EPG) Juridiction Unifiée du Brevet (JUB) almost there. Sam Granata Judge Court of Appeal Antwerp Agoria Conference on the UP and UPC October 20,
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 19 March /08 PI 14
COUNCIL OF THE EUROPEAN UNION Brussels, 19 March 2008 7728/08 PI 14 WORKING DOCUMT from: Presidency to: Working Party on Intellectual Property (Patents) No. prev. doc. : 7001/08 PI 10 Subject : European
More informationFordham IP Conference 4-5 April 2013 Remedies session Laëtitia Bénard Cross-border injunctions for registered IP rights in Europe
Fordham IP Conference 4-5 April 2013 Remedies session Laëtitia Bénard Cross-border injunctions for registered IP rights in Europe 1 I. General rule for all IP rights: Brussels Regulation No 44/2001 A right
More informationThe Progress to Date with the Unitary European Patent and the Unified Patent Court for Europe
Journal of Intellectual Property Rights Vol 18, November 2013, pp 584-588 European IP Developments The Progress to Date with the Unitary European Patent and the Unified Patent Court for Europe Trevor Cook
More informationUnited Kingdom. By Penny Gilbert, Kit Carter and Stuart Knight, Powell Gilbert LLP
Powell Gilbert LLP United Kingdom United Kingdom By Penny Gilbert, Kit Carter and Stuart Knight, Powell Gilbert LLP Q: What options are open to a patent owner seeking to enforce its rights in your jurisdiction?
More informationPreliminary set of provisions for the Rules of Procedure ( Rules ) of the Unified Patent Court
15 th 16 th draft of 31 st May 2013 Of 31 January 2014 17 th draft Of 31 October 2014 Preliminary set of provisions for the Rules of Procedure ( Rules ) of the Unified Patent Court Status 1. First draft
More informationUnitary Patent and Unified Patent Court
Unitary Patent and Unified Patent Court www.bardehle.com 2 Content 5 1. The patent-reform package 5 1.1 Legal basis 7 1.2 Legislative objectives 8 1.3 The legal instruments 8 1.3.1 The Regulation on the
More informationEUROPEAN GENERIC MEDICINES ASSOCIATION
EUROPEAN GENERIC MEDICINES ASSOCIATION POSITION PAPER POSITION PAPER ON THE REVIEW OF DIRECTIVE 2004/48/EC ON THE ENFORCEMENT OF INTELLECTUAL PROPERTY RIGHTS JUNE 2011 EGA EUROPEAN GENERIC MEDICINES ASSOCIATION
More informationJudicial training in the framework of the Unified Patent Court as a prerequisite for the success of the Unitary Patent System
ERA Forum (2015) 16:1 6 DOI 10.1007/s12027-015-0378-z EDITORIAL Judicial training in the framework of the Unified Patent Court as a prerequisite for the success of the Unitary Patent System Florence Hartmann-Vareilles
More informationThe Unitary Patent & Unified Patent Court
The Unitary Patent & Unified Patent Court Guide to key features & perspectives Winter 2017 The European IP Firm Overview A new system for granting and litigating patents in Europe may become a reality
More informationThe World Intellectual Property Organization
The World Intellectual Property Organization The World Intellectual Property Organization is an international organization dedicated to ensuring that the rights of creators and owners of intellectual property
More informationBelgium. Belgium. By Annick Mottet Haugaard and Christian Dekoninck, Lydian, Brussels
Lydian By Annick Mottet Haugaard and Christian Dekoninck, Lydian, Brussels 1. What are the most effective ways for a European patent holder whose rights cover your jurisdiction to enforce its rights in
More informationUNITARY PATENT PROTECTION (UPP) PACKAGE
UNITARY PATENT PROTECTION (UPP) PACKAGE LECCA & ASSOCIATES Ltd. August 1-2, 2014 Hong Kong, China SAR Objectives & Issues Creation of Unitary Patent (UP) Unitary Patent Court (UPC) A single harmonized
More informationThe European Patent and the UPC
The European Patent and the UPC Robin Keulertz German Patent Attorney, European Patent Attorney, European Trademark and Design Attorney February 22nd, 2019 Current European Patent Grant Procedure Invention
More informationPatent litigation. Block 3. Module UPC Law Essentials
Patent litigation. Block 3; Module UPC Law Patent litigation. Block 3. Module UPC Law Essentials Article 32(f) of the UPC Agreement ( UPCA ) states that subject to the transitional regime of Article 83
More informationPATENT SYSTEM STATUS OF REFORMS
THE UNITARY PATENT SYSTEM STATUS OF REFORMS April 06, 2017 1. STATUS OF REFORMS On December 11, 2012 the EU Parliament approved the implementation of the Unitary PatentSystembasedonaUnitaryPatentRegulation
More informationA Guide through Europe s New Unified Patent System
A Guide through Europe s New Unified Patent System June 2013 (Version 2) 1 1 This is an updated version of version 1 of the Guide. Boston Brussels Chicago Düsseldorf Frankfurt Houston London Los Angeles
More informationBrinkhof. Defendant s Objection to the Application for Provisional Measures. Merva. Pentapharm
Brinkhof Unified Patent Court Local Division Milan [Address] Action number: [ ] Date oral hearing: 20 September 2016 Date submission: 6 September 2016 Defendant s Objection to the Application for Provisional
More informationWORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING
43 rd World Intellectual Property Congress Seoul, Korea WORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING October 21, 2012 John Kim* Admitted to practice in Maryland, the District of Columbia,
More informationYoung EPLAW Congress. Bolar provision: a European tour. Brussels, 27 April 2015 Guillaume Bensussan Kathy Osgerby Agathe Michel de Cazotte
Young EPLAW Congress Bolar provision: a European tour Brussels, 27 April 2015 Guillaume Bensussan Kathy Osgerby Agathe Michel de Cazotte Introduction Bolar provision: a European tour Part 1 UK A) Recent
More informationThe Unitary Patent & Unified Patent Court. Guide to Key Features & Perspectives
The Unitary Patent & Unified Patent Court Guide to Key Features & Perspectives August 2016 A new system for granting and litigating patents in Europe may become a reality in the future. There are two parts
More informationPatent Protection: Europe
Patent Protection: Europe Currently available options: National Patent European Patent (EP) Centralised registration procedure (bundle of nationally enforceable patents) Applicant designates the states
More information17229/09 LK/mg 1 DG C I
COUNCIL OF THE EUROPEAN UNION Brussels, 7 December 2009 17229/09 PI 141 COUR 87 NOTE from: General Secretariat of the Council to: Delegations No. prev. doc.: 16114/09 ADD 1 PI 123 COUR 71 Subject: Enhanced
More informationThe Current Status of the Unitary Patent Package
The Current Status of the Unitary Patent Package Pierre Véron Honorary President EPLAW (European Patent Lawyers Association) Member of the Expert Panel group of the Unified Patent Court Member of the Drafting
More informationIP & IT Bytes. November Patents: jurisdiction and declaratory relief
November 2016 IP & IT Bytes First published in the November 2016 issue of PLC Magazine and reproduced with the kind permission of the publishers. Subscription enquiries 020 7202 1200. Patents: jurisdiction
More informationPatents in Europe 2016/2017. Helping business compete in the global economy
In association with Greece Maria Athanassiadou and Henning Voelkel Dr Helen G Papaconstantinou and Partners Patents in Europe 2016/2017 Helping business compete in the global economy Dr Helen G Papaconstantinou
More informationUnitary Patent Procedure before the EPO
Unitary Patent Procedure before the EPO Platform Formalities Officers EPO The Hague H.-C. Haugg Director Legal and Unitary Patent Division D.5.2.3 20 April 2017 Part I General Information What is the legal
More informationEffective Mechanisms for Challenging the Validity of Patents
Effective Mechanisms for Challenging the Validity of Patents Walter Holzer 1 S.G.D.G. Patents are granted with a presumption of validity. 2 A patent examiner simply cannot be aware of all facts and circumstances
More informationEurope-wide patent protection and the competence of the Unified Patent Court
the competence of ERA conference on recent developments in European private and business law Trier, 20 November 2014 by Dr Klaus Grabinski Judge, Federal Supreme Court I. Status quo 1. National patent
More informationUnderstanding the Unified Patent Court: The Next Rocket-Docket for Patent Owners?
Understanding the Unified Patent Court: The Next Rocket-Docket for Patent Owners? By Kevin R. Greenleaf, Michael W. O Neill, and Aloys Hüettermann Kevin R. Greenleaf is a counsel at Dentons US LLP where
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DECISION
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.12.2003 COM(2003) 827 final 2003/0326 (CNS) Proposal for a COUNCIL DECISION conferring jurisdiction on the Court of Justice in disputes relating to the
More informationIndustrial Property Course Patents, 2018 Edition Corso di Proprietà Industriale Brevetti, edizione 2018 Politecnico di Milano
Industrial Property Course Patents, 2018 Edition Corso di Proprietà Industriale Brevetti, edizione 2018 Politecnico di Milano Module Date Time Topic lecturers A general introduction into law, including
More informationOur Speakers: Rudy I. Kratz Partner; Fitch, Even, Tabin & Flannery LLP. Tony Wray Director and Founder; Optimus Patents Ltd.
Our Speakers: Rudy I. Kratz Partner; Fitch, Even, Tabin & Flannery LLP Tony Wray Director and Founder; Optimus Patents Ltd. August 30, 2016 2016 Fitch, Even, Tabin & Flannery LLP First of All... These
More informationDispute Resolution Around the World. Germany
Dispute Resolution Around the World Germany Dispute Resolution Around the World Germany 2011 Dispute Resolution Around the World Germany Table of Contents 1. Legal System... 1 2. Courts... 1 3. Legal
More informationUnitary Patent and Unified Patent Court
Unitary Patent and Unified Patent Court www.bardehle.com Content 5 1. The patent-reform package 6 1.1 Legal basis 8 1.2 Legislative objectives 8 1.3 The legal instruments 8 1.3.1 The Regulation on the
More informationUnitary Patent in Europe & Unified Patent Court (UPC)
Unitary Patent in Europe & Unified Patent Court (UPC) An overview and a comparison to the classical patent system in Europe 1 Today s situation: Obtaining patent protection in Europe Direct filing and
More informationProposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
EUROPEAN COMMISSION Brussels, 26.7.2013 COM(2013) 554 final 2013/0268 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EU) No 1215/2012 on jurisdiction
More informationHow patents work An introduction for law students
How patents work An introduction for law students 1 Learning goals The learning goals of this lecture are to understand: the different types of intellectual property rights available the role of the patent
More informationEurope s New Unitary Patent System
Europe s New Unitary Patent System What you need to know and do now A huge change in European patent law is on our doorstep. Decisions need to be made strategies need to be set. Kilburn & Strode partners
More informationGermany. Henrik Holzapfel and Martin Königs. McDermott Will & Emery
GERMANY Germany Henrik Holzapfel and Martin Königs Patent Enforcement Proceedings 1 Lawsuits and courts What legal or administrative proceedings are available for enforcing patent rights against an infringer?
More informationAIPLA Annual Meeting, Washington DC 23 October Licenses in European Patent Litigation
AIPLA Annual Meeting, Washington DC 23 October 2014 Licenses in European Patent Litigation Dr Jochen Bühling, Attorney-at-law/Partner, Krieger Mes & Graf v. Groeben Olivier Nicolle, French and European
More informationPresumption Of Patent Validity In Patent Litigations The New Trends
Presumption Of Patent Validity In Patent Litigations The New Trends 11 th EGA Legal Affairs Forum March 27, 2015 Kristof Roox, Partner, Crowell & Moring Contents A. Prima facie" validity of patents in
More informationUnified Patent Court & Rules of Procedure Where do we stand
Unified Patent Court & Rules of Procedure Where do we stand Kevin Mooney The Court Rules State of Play 15th Draft submitted for public consultation in June 2013 Consultation ended 30th September 2013 16
More informationThe Assertion of Patents in Germany. Dr. Roland Kehrwald Wildanger Kehrwald Graf v. Schwerin & Partner mbb
The Assertion of Patents in Germany Dr. Roland Kehrwald Wildanger Kehrwald Graf v. Schwerin & Partner mbb October 2016 Overview of Contents Introduction and subject of presentation A. Perspective of Patent
More informationPatents in Europe 2011/2012. Greece Lappa
Patents in Europe 2011/2012 Lappa By Eleni Lappa, Drakopoulos Law Firm, Athens 1. What are the most effective ways for a European patent holder whose rights cover your jurisdiction to enforce its rights
More informationOlivier MANDEL, Partner, MANDEL & ASSOCIES Law firm
Olivier MANDEL, Partner, MANDEL & ASSOCIES Law firm Ø An alternative (essentially to London) for business operators in dispute resolution by setting up an attractive judicial system in Paris ØIn order
More information9107/15 TB/at 1 DG G 3 B
Council of the European Union Brussels, 21 May 2015 (OR. en) Interinstitutional Files: 2011/0093 (COD) 2011/0094 (CNS) 9107/15 COMPET 244 PI 35 NOTE From: To: General Secretariat of the Council Council
More informationCOMMENTARY. Pan-European Preliminary Injunctions in Patent Infringement Proceedings: Do We Still Need a European Unified Court System?
August 2012 JONES DAY COMMENTARY Pan-European Preliminary Injunctions in Patent Infringement Proceedings: Do We Still Need a European Unified Court System? The Court of Justice of the European Union (
More informationKey Features of the Primary European Patent Litigation Countries
Volume 26, Number 6 June 2012 Reproduced with permission from World Intellectual Property Report, 26 WIPR 38, 06/01/2012. Copyright 2012 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
More informationBrexit Implications on the Life Sciences Sector
Brexit Implications on the Life Sciences Sector Holger Stratmann Attorney at Law, Partner 1 Life Science IP Seminar 2017 Separating Facts From Fiction Impact On Existing IP The Unknown Future What To Do
More informationStrategies for successful Patent Enforcement in Germany. Michael Knospe, Partner, SJ Berwin LLP
Strategies for successful Patent Enforcement in Germany Michael Knospe, Partner, SJ Berwin LLP 1 Overview 1. Some statistical data 2. Why Germany? 3. Infringement proceedings 4. Preliminary injunction
More informationDraft Rules relating to Unitary Patent Protection revised version of Rules 1 to 11 of SC/16/13
SC/22/13 Orig.: en Munich, 22.11.2013 SUBJECT: SUBMITTED BY: ADDRESSEES: Draft Rules relating to Unitary Patent Protection revised version of Rules 1 to 11 of SC/16/13 President of the European Patent
More informationIP Litigation in Life Sciences Germany 2016
IP Litigation in Life Sciences Germany 2016 Dr. Jan B. Krauss, Patent Attorney, Munich 2016 WIPO Conference Life Sciences Dispute Resolution Agenda The current landscape of life sciences enforcement in
More informationUnitary Patent Guide. Obtaining, maintaining and managing Unitary Patents
Unitary Patent Guide Obtaining, maintaining and managing Unitary Patents 1 st edition August 2017 Unitary Patent Guide Obtaining, maintaining and managing Unitary Patents 1st edition, 2017 Contents A.
More informationEnglish jurisdiction clauses should commercial parties change their approach?
Brexit legal consequences for commercial parties English jurisdiction clauses should commercial parties change their approach? February 2016 Issue in focus In our first Specialist paper on the legal consequences
More informationThe Current Status of the European Patent Package
The Current Status of the European Patent Package Pierre Véron Honorary President EPLAW (European Patent Lawyers Association) Member of the Expert Panel group of the Unified Patent Court Member of the
More informationCROSS-BORDER PATENT DISPUTES: UPC OR ARBITRATION
CROSS-BORDER PATENT DISPUTES: UPC OR ARBITRATION APPLE VS SAMSUNG ANA GEORGINA ALBA BETANCOURT QUEEN MARY, UNIVERSITY OF LONDON OUTLINE 1. Overview of the Apple vs Samsung Patent case 2. Overview of the
More informationPatent Litigation in Taiwan: overview
Patent Litigation in Taiwan: overview Resource type: Country Q&A Status: Law stated as at 01-Jan-2016 Jurisdiction: Taiwan A Q&A guide to patent litigation in Taiwan. The Q&A gives a high level overview
More informationIP in a World of Change: Europe and Brexit; United States and its exit from the TPP: Where does IP Protection come in?
IP in a World of Change: Europe and Brexit; United States and its exit from the TPP: Where does IP Protection come in? Europe and Brexit - Exhaustion and litigation issues Ari Laakkonen, Powell Gilbert
More informationBrexit English law and the English Courts
Brexit Law your business, the EU and the way ahead Brexit English law and the English Courts Introduction June 2018 One of the key questions that commercial parties continue to raise in relation to Brexit,
More informationQuestionnaire 2. HCCH Judgments Project
Questionnaire 2 HCCH Judgments Project Introduction 1) An important current project of the Hague Conference on Private International Law (HCCH) is the development of a convention on the recognition and
More informationCOMPULSORY LICENCE in Germany. Markus Rieck LL.M.
COMPULSORY LICENCE in Germany Markus Rieck LL.M. 1 1877 - GERMAN PATENT ACT Bundesarchiv, Bild 183-R68588 / P. Loescher & Petsch / CC-BY-SA 3.0 2 Public interest Dependent patent Plant breeders privilege*
More informationAbout Allen & Overy LLP
Allen & Overy LLP's Response to the European Commission Staff Working Document "Towards a coherent European approach to collective redress", SEC (2011) 173 final About Allen & Overy LLP Allen & Overy LLP
More informationDAY ONE: Monday, February 26, 2018
7:30 8:30 Breakfast & Registration 8:30 8:45 Welcome and Introductions (Cooper, Rea, Weinlein) 8:45 10:00 [Panel 1 (or Keynotes)] Legislative And Administrative Efforts To Make United States Patent Protection
More informationScottish Universities Legal Network on Europe
Scottish Universities Legal Network on Europe INTERNATIONAL PRIVATE LAW: FAMILY LAW Written by Professor J M Carruthers, University of Glasgow Professor E B Crawford, University of Glasgow. Contact: Janeen.Carruthers@gla.ac.uk
More informationPatent litigation. Block 1. Module Priority. Essentials: Priority. Introduction
Patent litigation. Block 1. Module Priority Introduction Due to the globalisation of markets and the increase of inter-state trade, by the end of the nineteenth century there was a growing need for internationally
More informationIP system and latest developments in China. Beijing Sanyou Intellectual Property Agency Ltd. June, 2015
IP system and latest developments in China Beijing Sanyou Intellectual Property Agency Ltd. June, 205 Main Content. Brief introduction of China's legal IP framework 2. Patent System in China: bifurcated
More information4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA
4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA Provisions of the Indian patent law were compared with the relevant provisions of the patent laws in U.S., Europe and
More informationThe Court of Justice. Composition, jurisdiction and procedures
The Court of Justice Composition, jurisdiction and procedures To build Europe, certain States (now 28 in number) concluded treaties establishing first the European Communities and then the European Union,
More information